Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Carcinoma, Hepatocellular 12Liver Neoplasms 3Prostatic Neoplasms 2Colorectal Neoplasms 2Neuroendocrine Tumors 1Liver Diseases 1Liver Abscess 1Digestive System Diseases 1Carcinoma 1Breast Neoplasms 1Adenoma 1

Interventions

Sorafenib 68Bevacizumab 44Oxaliplatin 25Doxorubicin 22Gemcitabine 21Fluorouracil 21Radiosurgery 20Nivolumab 19durvalumab 18Radiofrequency Ablation 18pembrolizumab 17lenvatinib 17Cisplatin 17Capecitabine 17atezolizumab 14Leucovorin 14Hepatectomy 14Radiotherapy 12tremelimumab 10Irinotecan 10Drug Therapy 10Cyclophosphamide 10Carboplatin 10Blood Specimen Collection 10Ipilimumab 9regorafenib 8Liver Transplantation 8Everolimus 8Cryosurgery 8Chemotherapy, Adjuvant 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Liver Neoplasms × gadolinium ethoxybenzyl DTPA × Clear all
NCT04288323 2026-02-12

Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosis

University of California, San Diego

Phase 4 Completed
79 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT03215355 2021-01-27

Improving CBCT for Liver IG-SBRT Using Gadoxetate Disodium

Nova Scotia Health Authority

Phase 4 Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT01043523 2016-11-28

Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions.

Bayer

Completed
52 enrolled 27 charts
Gastrointestinal

Adenoma, Carcinoma, Carcinoma, Hepatocellular, Liver Abscess, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡